Periprocedural bridging anticoagulation: current perspectives.
Research article published in American journal of therapeutics (2011)
Abstract
Perioperative management of patients on chronic anticoagulant use involves balancing individual risk for thromboembolism and bleeding. Discontinuation of antithrombotic therapy can place patients at increased risk of thromboembolic complications, whereas continuing antithrombotic therapy can increase procedure-related bleeding risk. Temporary perioperative substitution of low-molecular weight heparin or unfractionated heparin in place of warfarin, "the bridge therapy" is often used in the periprocedural period, but the indications and timing of this is still uncertain. This review addresses the risk stratification of patients according to thromboembolic risk, indications, timing, and duration, and a practical approach to bridge therapy.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Zusammenfassung
Periprocedural bridging anticoagulation: current perspectives.
Warum dies für die Hirudotherapie relevant ist
This review addresses the risk stratification, indications, timing, and practical approaches to periprocedural bridging anticoagulation, which involves substituting heparin for warfarin temporarily. It focuses on balancing the risks of thromboembolism and procedure-related bleeding during invasive procedures. There is no defensible link to hirudotherapy, the leech secretome, or the American Society of Hirudotherapy's domain. The abstract focuses strictly on conventional medical management with warfarin and heparin. No leeches, hirudin, or related therapies are mentioned or implied in the text, making it entirely irrelevant to the society's focus.
Zitation
Periprocedural bridging anticoagulation: current perspectives.
Palaniswamy et al. · American journal of therapeutics, 2011
Verwandter klinischer Kontext
Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist
Zur ASH-Bibliothek hinzugefügt: May 28, 2026 · Letzte Aktualisierung der Website: June 18, 2026